Enanta Pharmaceuticals (ENTA) Current Assets (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Current Assets of $178.4 million for Q1 2026, down 26.54% year-on-year from $242.9 million in Q1 2025, and down 10.2% on a QoQ basis from $198.7 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Current Assets data on file, last reported at $178.4 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 26.54% year-over-year to $178.4 million; the trailing twelve-month figure through Mar 2026 stood at $178.4 million (down 26.54% YoY), and the FY2025 full-year result was $204.3 million, down 31.85% from the prior year.
- Current Assets for Q1 2026 stood at $178.4 million, down from $198.7 million in the prior quarter.
- Across five years, Current Assets topped out at $448.5 million in Q2 2023 and bottomed at $178.4 million in Q1 2026.
- The 5-year median for Current Assets is $286.6 million (2024), against an average of $296.2 million.
- The widest annual swing landed in 2023, when Current Assets surged 43.26%; it then tumbled 36.1% in 2024.
- A 5-year view of Current Assets shows it stood at $283.7 million in 2022, then jumped by 37.57% to $390.3 million in 2023, then sank by 31.3% to $268.1 million in 2024, then retreated by 25.9% to $198.7 million in 2025, then fell by 10.2% to $178.4 million in 2026.
- The last three Current Assets figures came in at $178.4 million (Q1 2026), $198.7 million (Q4 2025), and $204.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 178.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 178.41 Mn |
| Dec 31, 2025 | 198.68 Mn |
| Sep 30, 2025 | 204.34 Mn |
| Jun 30, 2025 | 222.71 Mn |
| Mar 31, 2025 | 242.86 Mn |
| Dec 31, 2024 | 268.15 Mn |
| Sep 30, 2024 | 299.85 Mn |
| Jun 30, 2024 | 286.58 Mn |
| Mar 31, 2024 | 351.03 Mn |
| Dec 31, 2023 | 390.30 Mn |
| Sep 30, 2023 | 422.79 Mn |
| Jun 30, 2023 | 448.47 Mn |
| Mar 31, 2023 | 271.14 Mn |
| Dec 31, 2022 | 283.70 Mn |
| Sep 30, 2022 | 311.71 Mn |
| Jun 30, 2022 | 313.04 Mn |
| Mar 31, 2022 | 341.87 Mn |
| Dec 31, 2021 | 326.96 Mn |
| Sep 30, 2021 | 319.02 Mn |
| Jun 30, 2021 | 321.16 Mn |
| Mar 31, 2021 | 428.22 Mn |
| Dec 31, 2020 | 445.94 Mn |
| Sep 30, 2020 | 436.84 Mn |
| Jun 30, 2020 | 413.38 Mn |
| Mar 31, 2020 | 402.71 Mn |
| Dec 31, 2019 | 440.51 Mn |
| Sep 30, 2019 | 401.85 Mn |
| Jun 30, 2019 | 451.26 Mn |
| Mar 31, 2019 | 423.84 Mn |
| Dec 31, 2018 | 423.31 Mn |
| Sep 30, 2018 | 380.39 Mn |
| Jun 30, 2018 | 339.89 Mn |
| Mar 31, 2018 | 305.68 Mn |
| Dec 31, 2017 | 247.63 Mn |
| Sep 30, 2017 | 237.82 Mn |
| Jun 30, 2017 | 206.12 Mn |
| Mar 31, 2017 | 190.59 Mn |
| Dec 31, 2016 | 224.07 Mn |
| Sep 30, 2016 | 232.16 Mn |
| Jun 30, 2016 | 241.79 Mn |
| Mar 31, 2016 | 242.67 Mn |
| Dec 31, 2015 | 209.02 Mn |
| Sep 30, 2015 | 170.64 Mn |
| Jun 30, 2015 | 172.64 Mn |
| Mar 31, 2015 | 177.78 Mn |
| Dec 31, 2014 | 185.10 Mn |
| Sep 30, 2014 | 107.98 Mn |
| Jun 30, 2014 | 111.68 Mn |
| Mar 31, 2014 | 99.35 Mn |
| Dec 31, 2013 | 94.38 Mn |
| Sep 30, 2013 | 104.71 Mn |
| Jun 30, 2013 | 97.87 Mn |
| Mar 31, 2013 | 111.66 Mn |
| Sep 30, 2012 | 47.31 Mn |